Prosecution Insights
Last updated: May 29, 2026

UCL Business Ltd

23 pending office actions • 16 art units • 21 examiners • 0 of 23 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days

Portfolio Summary

23
Total Pending OAs
12
Non-Final OAs
10
Final Rejections
1
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 23 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

17
Overdue
0
Due this week
6
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 23 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (17)Due ≤ 30 days (6)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
19
Medium (83%)
2
Easy (9%)
2
Unknown (9%)

Rejection Statute Mix

BucketCases
§103 only18 (78%)
§102 only1 (4%)
§112 only2 (9%)
No statute on record2 (9%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

19
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

230 h
Manual time on pending OAs
46 h
Time saved (low, 20%)
80 h
Time saved (mid, 35%)
2.0 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
BAUSCH, SARAE L 2 29.0% +43.8%
HILL, KEVIN KAI 2 36.2% +33.4%
KIM, DANIELLE A 1 37.2% +58.0%
BURKHART, MICHAEL D 1 62.4% +10.9%
KELLOGG, MICHAEL S 1 42.1% +55.5%
ASGHAR, AMINAH 1 62.8% +45.2%
BOR, HELENE CATHERINE 1 51.1% +30.0%
ZIMMER, ANTHONY J 1 74.7% +20.5%
ALLEN, SARAH ELIZABETH 1 61.9% +44.4%
BREWSTER, HAYDEN R 1 61.9% +48.4%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17309348 DIFFERENTIAL METHYLATION BAUSCH, SARAE L 22d
18009936 METHODS FOR DETECTING AND PREDICTING BREAST CANCER BAUSCH, SARAE L 27d

Interview Candidates (12)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
16470933 THERAPEUTIC CELLS HILL, KEVIN KAI 98d overdue
18258414 A SYSTEM FOR POSITIONING A MEDICAL TOOL ASGHAR, AMINAH 86d overdue
18009320 CHIMERIC ANTIGEN RECEPTOR CELL HILL, KEVIN KAI 86d overdue
18017502 GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF ALLEN, SARAH ELIZABETH 71d overdue
18005577 PIEZOELECTRIC AND PIEZOCATALYTIC COMPOSITE MATERIAL, AND METHODS OF USING AND FORMING IT BREWSTER, HAYDEN R 49d overdue
18042899 PRODUCTION OF INORGANIC SALTS ZIMMER, ANTHONY J 44d overdue
18194235 ELECTROCARDIOGRAPHIC IMAGING SYSTEM AND METHOD BOR, HELENE CATHERINE 28d overdue
18349406 APPARATUSES AND METHODS FOR USE IN ULTRASOUND OPTICAL IMAGING KELLOGG, MICHAEL S 15d overdue

Top Art Units

Art UnitApps
1638 3
3797 2
1736 2
1699 2
1683 2
1632 2
1613 1
3798 1
1637 1
1779 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18505809 COMPOSITIONS FOR THE TREATMENT OF A DISEASE OF THE URINARY TRACT AND TREATMENT OF A DISEASE INVOLVING THE INTRACELLULAR DELIVERY OF THE PARTICLE OR A MEDICAMENT CONTAINED THEREIN KIM, DANIELLE A 1613 §103 Non-Final OA 1d overdue Pending Nov 09, 2023
18282061 GENE THERAPY COMPOSITION AND TREATMENT OF RIGHT VENTRICULAR ARRHYTHMOGENIC CARDIOMYOPATHY BURKHART, MICHAEL D 1638 Other Final Rejection 3d overdue Pending Sep 14, 2023
18349406 APPARATUSES AND METHODS FOR USE IN ULTRASOUND OPTICAL IMAGING KELLOGG, MICHAEL S 3798 §103 Non-Final OA 15d overdue Pending Jul 10, 2023
18258414 A SYSTEM FOR POSITIONING A MEDICAL TOOL ASGHAR, AMINAH 3797 §103 Final Rejection 86d overdue Pending Jun 20, 2023
18194235 ELECTROCARDIOGRAPHIC IMAGING SYSTEM AND METHOD BOR, HELENE CATHERINE 3797 §103 Non-Final OA 28d overdue Pending Mar 31, 2023
18042899 PRODUCTION OF INORGANIC SALTS ZIMMER, ANTHONY J 1736 §103 Non-Final OA 44d overdue Pending Feb 24, 2023
18017502 GENE THERAPY VECTOR FOR eEF1A2 AND USES THEREOF ALLEN, SARAH ELIZABETH 1637 §103 Non-Final OA 71d overdue Pending Jan 23, 2023
18005577 PIEZOELECTRIC AND PIEZOCATALYTIC COMPOSITE MATERIAL, AND METHODS OF USING AND FORMING IT BREWSTER, HAYDEN R 1779 §103 Non-Final OA 49d overdue Pending Jan 13, 2023
18009936 METHODS FOR DETECTING AND PREDICTING BREAST CANCER BAUSCH, SARAE L 1699 §102 Non-Final OA 27d Pending Dec 12, 2022
18009945 METHODS FOR DETECTING AND PREDICTING CANCER AND/OR CIN3 KENNEDY, SARAH JANE 1682 Other Non-Final OA 72d overdue Pending Dec 12, 2022
18009320 CHIMERIC ANTIGEN RECEPTOR CELL HILL, KEVIN KAI 1638 §103 Final Rejection 86d overdue Pending Dec 08, 2022
17928457 SYNTHESIS OF NANOPARTICLES SPEER, JOSHUA MAXWELL 1736 §103 Final Rejection 8d Pending Nov 29, 2022
17930815 MEMBRANE-SPANNING NANOPORES GUSSOW, ANNE 1683 §103 Non-Final OA 59d overdue Pending Sep 09, 2022
17793221 DRUG ELUTING BIOMATERIALS PRAGANI, RAJAN 1614 §103 Non-Final OA 12d Pending Jul 15, 2022
17846157 DIAGNOSIS OF FRONTOTEMPORAL DEMENTIA KAPUSHOC, STEPHEN THOMAS 1683 §103 Final Rejection 8d overdue Pending Jun 22, 2022
17786187 NEW THERAPY KLINKEL, KORTNEY L 1627 §103 Final Rejection 96d overdue Pending Jun 16, 2022
17783167 GENE THERAPY COMPOSITION AND TREATMENT FOR MYH7-LINKED CARDIOMYOPATHY MOLOYE, TITILAYO 1632 §112 Final Rejection 16d Pending Jun 07, 2022
17775172 Extracellular Matrix Gels, and Organoid Cultures Comprising the Same SCHUBERG, LAURA J 1631 §103 Non-Final OA 31d overdue Pending May 06, 2022
17761677 GENE THERAPY COMPOSITION AND TREATMENT OF RIGHT VENTRICULAR ARRYTHMOGENIC CARDIOMYOPATHY REGLAS, GILLIAN CHELSEA 1632 §103 Non-Final OA 19d overdue Pending Mar 18, 2022
17641786 Methods and Apparatuses for Fabricating Polymeric Conformal Coatings, Parts Coated With Polymeric Conformal Coatings, and Optical Apparatus Including Said Parts BOWMAN, ANDREW J 1717 §103 Non-Final OA 1d overdue Pending Mar 09, 2022
17309348 DIFFERENTIAL METHYLATION BAUSCH, SARAE L 1699 §112 Final Rejection 22d Pending May 20, 2021
17044558 DRAINAGE DEVICE AND METHODS LEVY, BRANDON WILLIAM 3781 §103 Final Rejection 27d Pending Oct 01, 2020
16470933 THERAPEUTIC CELLS HILL, KEVIN KAI 1638 §103 Final Rejection 98d overdue Pending Jun 18, 2019

Managing UCL Business Ltd's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month